Beyond Wild Horses: Developing Innovation at Cytel
According to Cytel Vice President Yannis Jemiai, the clinical trials industry must remember that breakthrough technology combines expertise with user-experience. Jemiai has been invited to deliver a talk on innovation at the upcoming conference of the International Society for Clinical Biostatistics. The lecture, entitled, 'Beyond Wild Horses: Developing Innovation at Cytel,' will argue that the proliferation of the R programming language by study designers has created various breeds of wild horses within the clinical trials industry.
According to Jemiai, three critical factors are necessary to transcend from wild horse to car. The first factor, statistical expertise, can hardly be undervalued. However, expertise must combine with exceptional user experience to create a simple and easy-to-use product. The final factor is to ensure that innovative software still provides trusted results. The talk will explore ways to accomplish this in the clinical trials industry.
Related Items of Interest
* "Horse-and-pony" by arjecahn on flickr. - http://www.flickr.com/photos/arje/95322238/.